NCATS researchers will begin work on three new pre-clinical drug development projects for malaria, Lassa fever and two blood disorders through the Therapeutics for Rare and Neglected Diseases program.
NIH funds 22 consortia and a data center to study more than 200 rare diseases.
Read about new awards for the Tissue Chip for Drug Screening program, NCATS staff participation in the NIH Research Festival, and more.
Eleven institutions will collaborate to refine existing 3-D human tissue chips and integrate them to test the safety of drugs.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Apply by Jan. 15, 2015, for the Clinical and Translational Science Awards program.
New model of Gaucher disease advances scientific understanding of rare disorders.
- NIH Announces Grants for Frontotemporal Degeneration Research • NINDS, NCATS, NIA
- New Diagnostic Test Helps UCLA Doctors Pinpoint Mutations that Cause Rarest Genetic Diseases • University of California, Los Angeles
- UW to Serve as National Hub for Mentor Training as Part of Diversity Consortium • University of Wisconsin – Madison
- More News & Events...